Changes in the multidisciplinary management of rectal cancer from 2009 to 2015 and associated improvements in short‐term outcomes
Colorectal Disease2019Vol. 21(10), pp. 1140–1150
Citations Over TimeTop 15% of 2019 papers
Campbell S.D. Roxburgh, Paul Strombom, Patricio B. Lynn, A. Cercek, Mithat Gönen, J. Joshua Smith, Larissa K. Temple, Garrett M. Nash, J. G. Guillem, Phillip Paty, Jinru Shia, Efsevia Vakiani, Rona Yaeger, Zsofia K. Stadler, Neil H. Segal, D. Reidy, Anna M. Varghese, Abraham J. Wu, Christopher H. Crane, Marc J. Gollub, Leonard B. Saltz, J. Garcia‐Aguilar, Martin R. Weiser
Abstract
Shifts toward MRI-based staging, total neoadjuvant therapy and MIS occurred between 2009 and 2015. Over the same period, treatment responses improved, and lengths of stay and the incidence of complications decreased.
Related Papers
- → Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation(2017)23 cited
- → The Pathological Assessment of Total Mesorectal Excision: What Are the Relevant Resection Margins?(2005)7 cited
- → Meta-analysis of transanal vs laparoscopic total mesorectal excision of low rectal cancer: Importance of appropriate patient selection(2022)2 cited
- → Laparoscopic Liver Resection in Segment 7: Hepatic vein first approach with special reference to sufficient resection margin(2019)1 cited
- [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].(2006)